Menu
Exclusive meeting for Commercial Payors
August 23, 2023 | Sheraton Dallas Hotel – 400 Olive St. | Dallas, Texas
NHIA Home & Specialty Infusion Payor Summit
NHIA is pleased to hold its second annual one-day Payor Summit exclusively for leaders from commercial payors. The summit provides education, describes current trends, and aims to help payors leverage infusion services to lower the total cost of care.
This interactive meeting will benefit leaders from commercial payors with responsibilities for benefit structure, network decisions, value-based programing, and specialty infusion policy. Attendees will hear from home and specialty infusion experts and executives about opportunities and challenges facing the industry today and into the future.
There is no fee to attend; however, attendees are responsible for their own travel arrangements and expenses. Join NHIA leadership and payor executives at a welcome reception the evening before. Breakfast and lunch are provided for meeting attendees during the summit. Space will be limited and reserved on a first come first served basis.
This interactive meeting will benefit leaders from commercial payors with responsibilities for benefit structure, network decisions, value-based programing, and specialty infusion policy. Attendees will hear from home and specialty infusion experts and executives about opportunities and challenges facing the industry today and into the future.
There is no fee to attend; however, attendees are responsible for their own travel arrangements and expenses. Join NHIA leadership and payor executives at a welcome reception the evening before. Breakfast and lunch are provided for meeting attendees during the summit. Space will be limited and reserved on a first come first served basis.
Additional information
What to expect
The 2023 summit will focus on helping payors leverage the home and alternate site of care to manage drug spend; improve patient access; improve health equity by reaching rural, disabled and transportation-limited populations; improve quality and patient experience; and reduce administrative burden. This will include a review of the recommendations that resulted from the inaugural NHIA Payor Summit.
Topics will include:
- Infusion industry trends and implications of regulatory changes on access and utilization
- Addressing home infusion access for Medicare Advantage enrollees
- Reducing NOC: A review of new HCPCs for specialty injectables and infusions
- Reducing administrative work/burden when submitting commercial secondary claims for non-covered Medicare infusion therapies
- Empowering infusion providers to prevent costly hospitalizations and complications in the home parenteral nutrition patient
The Venue
Policies and Statements
The antitrust laws of the United States prohibit agreements, combinations and conspiracies in restraint of trade. Because NHIA and other trade and professional associations are, by definition, combinations of competitors, one element of a possible antitrust violation is always present, and only an action by the association that unreasonably restrains trade needs to occur for there to be an antitrust violation. Consequently, associations are common targets of antitrust plaintiffs and prosecutors. Attendees at NHIA events must avoid discussing certain subjects when they come together for meetings, conference calls, and other joint activities. While there is an important exception to the antitrust laws that permits coming together to influence policies and regulations, as a rule, attendees of meetings where competitors are present must adhere to the following guidelines:
Do not discuss prices, fees or rates, or features that can impact (raise, lower or stabilize) prices such as discounts, costs, terms and conditions of sale, warranties, or profit margins.
Do not personalize any discussion about payment rates, i.e., “this payment is not enough for me.”
Do not exchange data concerning fees, prices, production, sales, bids, costs, customer credit, or other business practices unless the exchange is made pursuant to a well-considered plan that has been approved by NHIA’s legal counsel.
Do not discuss your customers with your competitors.
Do not discuss or implement a plan to boycott any public program or another entity – this is not protected by the exception that permits competitors to influence legislation and regulations.
Do ensure that if questions arise about the legal aspects of NHIA’s activities or your individual responsibilities under the antitrust laws, you seek advice and counsel from your own counsel or from the staff and counsel of NHIA.
NHIA is committed to holding a safe event and meeting all federal, state, and local rules and regulations. Attendees are strongly encouraged to test for COVID-19 prior to attending and will attest that they will not attend if they test positive or if any symptoms are present.
Registrants will be asked to sign off on the following liability waiver:
Liability Waiver
I understand that travel and gathering involves risk of sickness, including sickness from COVID-19. I waive and release NHIA and their employees and agents, from and against claims, liabilities, and expenses arising from injury, sickness, or death from contraction or spread of COVID-19 or other communicable disease due to travel to or attendance at the NHIA Fall FIAC Meeting.
I understand it is my responsibility to determine whether to undertake common recommended precautions at the meeting including, but not limited to: taking a COVID-19 test prior to travel, wearing a mask in public areas, or maintaining distance from others.
I agree that if I develop any of the symptoms of COVID 19 (including but not limited to fever, chills, cough, shortness of breath, difficulty breathing, fatigue, muscle or body aches, headaches, new loss of taste or smell, sore throat, congestion, runny nose, nausea, vomiting, or diarrhea) at any time during the Fall FIAC Meeting, I will return to my hotel room immediately and notify NHIA team member, Jennifer Charron via email (jennifer.charron@nhia.org) or phone 603.234.0175.
The antitrust laws of the United States prohibit agreements, combinations and conspiracies in restraint of trade. Because NHIA and other trade and professional associations are, by definition, combinations of competitors, one element of a possible antitrust violation is always present, and only an action by the association that unreasonably restrains trade needs to occur for there to be an antitrust violation. Consequently, associations are common targets of antitrust plaintiffs and prosecutors. Attendees at NHIA events must avoid discussing certain subjects when they come together for meetings, conference calls, and other joint activities. While there is an important exception to the antitrust laws that permits coming together to influence policies and regulations, as a rule, attendees of meetings where competitors are present must adhere to the following guidelines:
Do not discuss prices, fees or rates, or features that can impact (raise, lower or stabilize) prices such as discounts, costs, terms and conditions of sale, warranties, or profit margins.
Do not personalize any discussion about payment rates, i.e., “this payment is not enough for me.”
Do not exchange data concerning fees, prices, production, sales, bids, costs, customer credit, or other business practices unless the exchange is made pursuant to a well-considered plan that has been approved by NHIA’s legal counsel.
Do not discuss your customers with your competitors.
Do not discuss or implement a plan to boycott any public program or another entity – this is not protected by the exception that permits competitors to influence legislation and regulations.
Do ensure that if questions arise about the legal aspects of NHIA’s activities or your individual responsibilities under the antitrust laws, you seek advice and counsel from your own counsel or from the staff and counsel of NHIA.
2022 summit Agenda
November 1, 2022
Join NHIA leadership and payor executives for an elegant networking reception upon arrival in Dallas.
November 2, 2022
We will kick off the morning with a full breakfast and ample time to network.
- Introductions
- Meeting Objectives
- Anti-trust rules
During the global pandemic many patients became aware of home-based care options for a wide range of services, including infusion. This session will discuss how the pandemic changed home infusion utilization, exposed vulnerabilities, and opened the door for new ways of delivering care while improving outcomes.
Today’s infusion providers offer a wide range of professional services that differentiate them from any other type of pharmacy. NHIA will summarize the service expectations payors should have of providers in their infusion networks and how to leverage these unique capabilities to lower the total cost of care.
Networking and refreshments
This moderated panel session of senior executives and CEO’s of home infusion’s largest organizations provides a window into the future direction of the industry. Panelists will share their experience navigating the pandemic, supply chain disruptions, staffing shortages, and why they are optimistic about the future of infusion.
Despite creating a home infusion therapy services benefit with the passage of 21st Century Cures in 2016, Medicare remains the only major payor in the U.S. to not offer beneficiaries straight-forward access to home infusion. This session explains why the Part B HIT benefit is failing to attract providers and how commercial plans can avoid the same pitfalls while adding value for Medicare Advantage enrollees.
Buffet lunch and networking time.
The infusion industry is primed for value-based payment opportunities. NHIA’s standardized definitions for patient outcome metrics provide the foundation for participation in value-based programs. This session will offer a vision for how value-based care could be integrated into a home infusion benefit.
Since the HIPAA compliant S-codes adopted in 2002 established a per day payment bundle for home infusion services, equipment, and supplies, the number of specialty infusions delivered at home has grown exponentially. This session reviews proposals to reduce the use of not-otherwise-classified codes.
Networking and refreshments
Attendees will hear from leaders of major health system programs about how hospitals are leveraging home and specialty infusion, the role of 340B, and how hospital at home programs intersect with home infusion.
How do we apply this information in a way that is beneficial to payors, providers and patients?
In November of 2022 the National Home Infusion Association (NHIA) was pleased to hold a one-day summit exclusively for leaders from commercial payors. The summit provided education, described current trends, and aimed to help payors leverage infusion services to lower the total cost of care.
The goal of this interactive meeting was to benefit leaders from commercial payors with responsibilities for benefit structure, network decisions, value-based programing, and specialty infusion policy. Attendees heard from home and specialty infusion experts and executives about opportunities and challenges facing the industry today and into the future.
